These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37209301)

  • 1. Disease-specific wearable sensor algorithms for profiling activity, gait, and balance in individuals with Charcot-Marie-Tooth disease type 1A.
    Dinesh K; White N; Baker L; Sowden JE; Behrens-Spraggins S; Wood E; Charles J; Herrmann DN; Sharma G; Eichinger K
    J Peripher Nerv Syst; 2023 Sep; 28(3):368-381. PubMed ID: 37209301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accelerate Clinical Trials in Charcot-Marie-Tooth Disease (ACT-CMT): A Protocol to Address Clinical Trial Readiness in CMT1A.
    Eichinger K; Sowden JE; Burns J; McDermott MP; Krischer J; Thornton J; Pareyson D; Scherer SS; Shy ME; Reilly MM; Herrmann DN
    Front Neurol; 2022; 13():930435. PubMed ID: 35832173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Afferent control of walking: are there distinct deficits associated to loss of fibres of different diameter?
    Nardone A; Corna S; Turcato AM; Schieppati M
    Clin Neurophysiol; 2014 Feb; 125(2):327-35. PubMed ID: 23948160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ascorbic acid for the treatment of Charcot-Marie-Tooth disease.
    Gess B; Baets J; De Jonghe P; Reilly MM; Pareyson D; Young P
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD011952. PubMed ID: 26662471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome measures in the clinical evaluation of ambulatory Charcot-Marie-Tooth 1A subjects.
    Mori L; Prada V; Signori A; Pareyson D; Piscosquito G; Padua L; Pazzaglia C; Fabrizi GM; Smania N; Picelli A; Schenone A;
    Eur J Phys Rehabil Med; 2019 Feb; 55(1):47-55. PubMed ID: 29898585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter Validation of the Charcot-Marie-Tooth Functional Outcome Measure.
    Mandarakas MR; Eichinger KJ; Bray P; Cornett KMD; Shy ME; Reilly MM; Ramdharry GM; Scherer SS; Pareyson D; Estilow T; McKay MJ; ; Herrmann DN; Burns J
    Neurology; 2024 Feb; 102(3):e207963. PubMed ID: 38237108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Charcot-Marie-Tooth Functional Outcome Measure (CMT-FOM).
    Eichinger K; Burns J; Cornett K; Bacon C; Shepherd ML; Mountain J; Sowden J; Shy R; Shy ME; Herrmann DN
    Neurology; 2018 Oct; 91(15):e1381-e1384. PubMed ID: 30232254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic Variability of Childhood Charcot-Marie-Tooth Disease.
    Cornett KM; Menezes MP; Bray P; Halaki M; Shy RR; Yum SW; Estilow T; Moroni I; Foscan M; Pagliano E; Pareyson D; Laurá M; Bhandari T; Muntoni F; Reilly MM; Finkel RS; Sowden J; Eichinger KJ; Herrmann DN; Shy ME; Burns J;
    JAMA Neurol; 2016 Jun; 73(6):645-51. PubMed ID: 27043305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upper and lower limb tremor in Charcot-Marie-Tooth neuropathy type 1A and the implications for standing balance.
    Silsby M; Yiannikas C; Fois AF; Kennerson ML; Kiernan MC; Fung VSC; Vucic S
    J Neurol; 2024 Apr; 271(4):1776-1786. PubMed ID: 38051345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deterioration in gait and functional ambulation in children and adolescents with Charcot-Marie-Tooth disease over 12 months.
    Kennedy R; Carroll K; Paterson KL; Ryan MM; McGinley JL
    Neuromuscul Disord; 2017 Jul; 27(7):658-666. PubMed ID: 28495045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Motor performance deterioration accelerates after 50 years of age in Charcot-Marie-Tooth type 1A patients.
    Tozza S; Bruzzese D; Pisciotta C; Iodice R; Esposito M; Dubbioso R; Ruggiero L; Topa A; Spina E; Santoro L; Manganelli F
    Eur J Neurol; 2018 Feb; 25(2):301-306. PubMed ID: 29053907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Employment status of patients with Charcot-Marie-Tooth type 1A.
    Bjelica B; Brankovic M; Bozovic I; Palibrk A; Kacar A; Rakocevic-Stojanovic V
    Acta Neurol Belg; 2022 Jun; 122(3):641-646. PubMed ID: 33491123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantifying gait impairment in individuals affected by Charcot-Marie-Tooth disease: the usefulness of gait profile score and gait variable score.
    Coghe G; Pau M; Mamusa E; Pisano C; Corona F; Pilloni G; Porta M; Marrosu G; Vannelli A; Frau J; Lorefice L; Fenu G; Marrosu MG; Cocco E
    Disabil Rehabil; 2020 Mar; 42(5):737-742. PubMed ID: 30334469
    [No Abstract]   [Full Text] [Related]  

  • 14. Patient-reported disease burden in the Accelerate Clinical Trials in Charcot-Marie-Tooth Disease Study.
    Rehbein T; Purks J; Dilek N; Behrens-Spraggins S; Sowden JE; Eichinger KJ; ; Burns J; Pareyson D; Scherer SS; Reilly MM; Shy ME; McDermott MP; Heatwole CR; Herrmann DN
    J Peripher Nerv Syst; 2024 Dec; 29(4):487-493. PubMed ID: 39390667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selected items from the Charcot-Marie-Tooth (CMT) Neuropathy Score and secondary clinical outcome measures serve as sensitive clinical markers of disease severity in CMT1A patients.
    Mannil M; Solari A; Leha A; Pelayo-Negro AL; Berciano J; Schlotter-Weigel B; Walter MC; Rautenstrauss B; Schnizer TJ; Schenone A; Seeman P; Kadian C; Schreiber O; Angarita NG; Fabrizi GM; Gemignani F; Padua L; Santoro L; Quattrone A; Vita G; Calabrese D; ; Young P; Laurà M; Haberlová J; Mazanec R; Paulus W; Beissbarth T; Shy ME; Reilly MM; Pareyson D; Sereda MW
    Neuromuscul Disord; 2014 Nov; 24(11):1003-17. PubMed ID: 25085517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative assessment of sciatic nerve changes in Charcot-Marie-Tooth type 1A patients using magnetic resonance neurography.
    Fortanier E; Ogier AC; Delmont E; Lefebvre MN; Viout P; Guye M; Bendahan D; Attarian S
    Eur J Neurol; 2020 Aug; 27(8):1382-1389. PubMed ID: 32391944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gait Pattern in Charcot-Marie-Tooth Disease Type 1A According to Disease Severity.
    Park J; Joo SY; Choi BO; Kim DH; Park JB; Lee JW; Kim DY
    J Pers Med; 2023 Oct; 13(10):. PubMed ID: 37888085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Charcot-Marie-Tooth disease and related inherited neuropathies.
    Murakami T; Garcia CA; Reiter LT; Lupski JR
    Medicine (Baltimore); 1996 Sep; 75(5):233-50. PubMed ID: 8862346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postural stabilization and balance assessment in Charcot-Marie-Tooth 1A subjects.
    Lencioni T; Rabuffetti M; Piscosquito G; Pareyson D; Aiello A; Di Sipio E; Padua L; Stra F; Ferrarin M
    Gait Posture; 2014 Sep; 40(4):481-6. PubMed ID: 25082324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postural instability in Charcot-Marie-Tooth 1A disease.
    Tozza S; Aceto MG; Pisciotta C; Bruzzese D; Iodice R; Santoro L; Manganelli F
    Gait Posture; 2016 Sep; 49():353-357. PubMed ID: 27491052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.